-
公开(公告)号：US4454257A
公开(公告)日：1984-06-12
申请号：US482399
申请日：1983-04-06
CPC分类号： C08G18/092 , C08G18/6755 , C08G2101/00 , Y10S521/902
摘要： Cured resins having excellent thermal and abrasion resistance and improved processability are provided by the addition polymerization of a compound having isocyanurate moieties, imide and/or amic acid moieties and ethylenically unsaturated moieties. An example of such a compound is the reaction product of an unsaturated cyclic anhydride such as maleic anhydride, an organic polyisocyanate such as a polymeric methylene phenyl polyisocyanate and water.
摘要翻译： 通过具有异氰脲酸酯部分的化合物，酰亚胺和/或酰胺酸部分和烯属不饱和部分的加成聚合来提供具有优异的耐热和耐磨性和改进加工性能的固化树脂。 这种化合物的实例是不饱和环酐如马来酸酐，有机多异氰酸酯如聚亚甲基苯基多异氰酸酯和水的反应产物。
-
公开(公告)号：US07740875B2
公开(公告)日：2010-06-22
申请号：US10960516
申请日：2004-10-08
申请人： Frederick J. Dechow
发明人： Frederick J. Dechow
CPC分类号： A61K8/37 , A61K8/042 , A61K8/345 , A61K8/42 , A61K8/466 , A61K8/553 , A61K9/0014 , A61K47/10 , A61K47/14 , A61K47/24 , A61Q19/00
摘要： A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions that further contain a cosmetic and/or pharmaceutical agent, along with the preparation and use thereof.
摘要翻译： 一种适用于将化妆品和/或药剂局部递送至含有至少两种生物相容性有机溶剂，极性脂质，表面活性剂，水，尿素和增稠剂的组合物的组合物，其中有机溶剂包括酯和二元和/ 或多元醇。 还公开了进一步含有化妆品和/或药剂以及其制备和用途的组合物。
-
公开(公告)号：US4954349A
公开(公告)日：1990-09-04
申请号：US325106
申请日：1989-03-17
CPC分类号： A61K9/2081 , A61K33/14
摘要： Solid oral composition for the treatment or prophylaxis of potassium and magnesium deficiency in skeletal and cardiac muscle containing about 3 to about 50 milliequivalent bioavailable potassium, about 0.1 to about 25 milliequivalent bioavailable magnesium, and a milliequivalent ratio of potassium to magnesium between about 2:1 and about 14:1, where the potassium is in a controlled release form, and methods of treating or preventing potassium and magnesium deficiency by oral administration of such compositions.
摘要翻译： 用于治疗或预防含有约3至约50毫当量生物可利用钾，约0.1至约25毫当量生物可利用镁的骨骼和心肌中钾和镁缺乏的固体口服组合物，以及约2:1之间的钾与镁的毫当量比 和约14:1，其中钾是控制释放形式，以及通过口服施用这些组合物治疗或预防钾和镁缺乏症的方法。
-
公开(公告)号：US4543261A
公开(公告)日：1985-09-24
申请号：US585700
申请日：1984-03-02
CPC分类号： A23C9/1465 , A23J1/205 , A23V2002/00
摘要： Salts and low molecular weight organic compounds are more efficiently separated from aqueous liquids by passing the liquid downwardly through a gel-type strong acid cation exchange resin, and eluting the resin. In a preferred embodiment, animal wastes and/or cheese whey are separated into usable components by removing insoluble organic material, then removing soluble proteins and/or enzymes by ion exchange with a macroporous weak base anion exchange resin, and then separating salts and nonionic organic compounds as above.
摘要翻译： 通过使液体向下通过凝胶型强酸阳离子交换树脂，并且洗脱树脂，将盐和低分子量有机化合物与水性液体更有效地分离。 在优选的实施方案中，通过除去不溶性有机物质将动物废物和/或干酪乳清分离成可用的组分，然后通过与大孔弱碱阴离子交换树脂离子交换除去可溶性蛋白质和/或酶，然后分离盐和非离子有机物 化合物如上所述。
-
5.发明授权Method for making crosslinked resin foams from an ethylenically unsaturated dicarboxylic acid anhydride and a polyisocyanate 失效由烯属不饱和二羧酸酐和多异氰酸酯制造交联树脂泡沫的方法
公开(公告)号：US4110274A
公开(公告)日：1978-08-29
申请号：US842720
申请日：1977-10-17
CPC分类号： C08J9/02 , C08G18/6755
摘要： Cellular resin bodies having apparent density less than about 30 pounds per cubic foot, where the resin has highly crosslinked three-dimensional ethylenic polymer structure having amic acid groups and/or cyclic imide linkages, are made by reaction of polyisocyanates with certain polymerizable ethylenically unsatured dicarboxylic acid cyclic anhydrides illustrated by maleic anhydride, and water. Mixture of the reactants and heating cause chemical interaction, evolution of carbon dioxide, ethylenic polymerization of intermediate reaction product, crosslinking, foaming and hardening of the resin. Cell formation is caused by carbon dioxide and water vapor in the resin reaction product. Resin foam products are infusible and insoluble in usual solvents and resist ignition and burning in air.
摘要翻译： {PG，1具有明显密度小于约30磅/立方英尺的细胞树脂体，其中树脂具有具有酰胺酸基和/或环状酰亚胺键的高度交联的三维乙烯性聚合物结构是通过多异氰酸酯与某些 马来酸酐所示的可聚合烯属不饱和二羧酸环状酸酐和水。 反应物和加热的混合物引起化学相互作用，二氧化碳的逸出，中间反应产物的乙烯聚合，交联，发泡和硬化树脂。 细胞形成是由树脂反应产物中的二氧化碳和水蒸汽引起的。 树脂泡沫产品是不可渗透的，不溶于通常的溶剂，可抵抗空气中的点燃和燃烧。
-
公开(公告)号：US20100305081A1
公开(公告)日：2010-12-02
申请号：US12856292
申请日：2010-08-13
申请人： Frederick J. Dechow
发明人： Frederick J. Dechow
IPC分类号： A61K31/57 , A61K31/21 , A61K31/7004 , A61K8/365 , A61P31/10 , A61P9/10 , A61P17/06 , A61K31/192 , A61K31/4174 , A61K31/4412 , A61Q19/00 , A61K31/137 , A61K47/24
CPC分类号： A61K9/7015 , A61K8/042 , A61K8/345 , A61K8/37 , A61K8/42 , A61K8/466 , A61K8/553 , A61K9/0012 , A61K9/0014 , A61K9/06 , A61K31/74 , A61Q19/00
摘要： A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions that further contain a cosmetic and/or pharmaceutical agent, along with the preparation and use thereof
摘要翻译： 一种适用于将化妆品和/或药剂局部递送至含有至少两种生物相容性有机溶剂，极性脂质，表面活性剂，水，尿素和增稠剂的组合物的组合物，其中有机溶剂包括酯和二元和/ 或多元醇。 还公开了进一步含有化妆品和/或药剂以及其制备和用途的组合物
-
公开(公告)号：US07776349B2
公开(公告)日：2010-08-17
申请号：US11246296
申请日：2005-10-11
申请人： Frederick J. Dechow
发明人： Frederick J. Dechow
CPC分类号： A61K9/7015 , A61K8/042 , A61K8/345 , A61K8/37 , A61K8/42 , A61K8/466 , A61K8/553 , A61K9/0012 , A61K9/0014 , A61K9/06 , A61K31/74 , A61Q19/00
摘要： A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions that further contain a cosmetic and/or pharmaceutical agent, along with the preparation and use thereof.
-
公开(公告)号：US20090191138A1
公开(公告)日：2009-07-30
申请号：US12022833
申请日：2008-01-30
申请人： Frederick J. Dechow
发明人： Frederick J. Dechow
IPC分类号： A61K8/18
CPC分类号： A61K8/37 , A61K8/042 , A61K8/42 , A61K8/466 , A61K8/553 , A61K9/0014 , A61K9/06 , A61K47/20 , A61K47/24 , A61Q3/00
摘要： A method is provided for improving the appearance of nails of a patient wherein a composition is topically applying to the patient's nail(s) exhibiting symptoms of at least one condition selected from the group consisting of onycholysis, onychoschizia or onychorrhexis and wherein the composition contains one or more biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and/or a dihydric and/or polyhydric alcohol is provided.
摘要翻译： 提供了一种用于改善患者指甲外观的方法，其中组合物局部施用于患者的指甲，所述指甲表现出至少一种选自由以下组成的组的症状：精神分裂症，迟发症或心律失常，并且其中所述组合物含有一种 或更多的生物相容性有机溶剂，极性脂质，表面活性剂，水，尿素和增稠剂，其中有机溶剂包括酯和/或二羟基和/或多元醇。
-
9.发明授权Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin 失效含有药学上可接受的不可消化的阴离子交换树脂的可口的降胆固醇血凝胶制剂
公开(公告)号：US4837255A
公开(公告)日：1989-06-06
申请号：US24224
申请日：1987-03-10
申请人： Frederick J. Dechow
发明人： Frederick J. Dechow
IPC分类号： A61K9/00 , A61K9/10 , A61K31/785 , A61K47/00 , A61P3/06
CPC分类号： A61K9/0095 , A61K31/785 , A61K9/0056 , Y10S514/801 , Y10S514/951 , Y10S514/974
摘要： A gel formation for oral administration having improved palatability comprising an effective hypocholesterolaemic amount of a uniform gelled dispersion of(a) between about 8 and about 20 percent by weight of a particulate, pharmaceutically acceptable, sparingly crosslinked non-digestible quaternary ammonium substituted polysytrene anion exchange resin having an average particle size below about 100 microns;(b) between about 4 and about 16 percent by weight of a pharmaceutically acceptable gelatin;(c) between about 0.015 and about 10 percent by weight of a natural or synthetic pharmaceutically acceptable sweetener;(d) between about 0.05 and about 2 percent by weight of a pharmaceutically acceptable organic acidulent;(e) between about 0.05 and about 5 percent by weight of one or more pharmaceutically acceptable flavoring or coloring agents or mixtures thereof; and(f) the remainder water.
摘要翻译： 用于口服给药的凝胶形成具有改善的适口性，其包含有效的低胆固醇血症量的均匀胶凝分散体（a）约8至约20重量％的颗粒，药学上可接受的，微量交联的不消化的季铵取代的聚阴离子交换 平均粒度低于约100微米的树脂; （b）约4至约16重量％的药学上可接受的明胶; （c）约0.015至约10重量％的天然或合成的药学上可接受的甜味剂; （d）约0.05至约2重量％的药学上可接受的有机酸性; （e）约0.05至约5重量％的一种或多种药学上可接受的调味剂或着色剂或其混合物; 和（f）剩余的水。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.017 秒)
